RecallRadar

FDA Food recall F-0134-2014

Protease: APEX 10-7082 CENTURY 7-152 EB 2-14511 EB 5-16901 EB 8-14861 EB 9-14191 EXCLZYME EXCLZYME EN GLOBAL 8-658 HFN 7-7113 META 10-185 M…

On 2013-11-20 the FDA classified a Class II recall of Protease: APEX 10-7082 CENTURY 7-152 EB 2-14511 EB 5-16901 EB 8-14861 EB 9-14191 EXCLZYME EXCLZYME EN GLOBAL 8-658 HFN 7-7113 META 10-185 M… by Specialty Enzymes And Biotechnologies, citing specialty Enzymes and Biotechnologies is recalling cellulase/mannanase and fungal protease because they may contain low levels of chloramphenicol.

Read the official FDA Food notice

AgencyFDA Food
Recall numberF-0134-2014
ClassificationClass II
Statusterminated
Initiated2013-10-03
Published2013-11-20
Last updated2026-09-13 11:48 UTC
CompanySpecialty Enzymes And Biotechnologies
DistributionUS

Product

Protease: APEX 10-7082 CENTURY 7-152 EB 2-14511 EB 5-16901 EB 8-14861 EB 9-14191 EXCLZYME EXCLZYME EN GLOBAL 8-658 HFN 7-7113 META 10-185 MHNHEM 2-158 PEPZYME AG PROTEASE - 1000 PROTEASE 250,000 SEB PRO FP 500 SEB PRO FP 600 SYS 7-7742 UT 11-216 N VEGPANZYME 1213 VEGPANZYME PLUS

Reason

Specialty Enzymes and Biotechnologies is recalling cellulase/mannanase and fungal protease because they may contain low levels of chloramphenicol.

Identifiers

code_info
Lot Numbers: 3071023 3071011 3071039 3061013 3051087 3071034 3031065 3031065 3051054; 3071020; 3061004 3071…Lot Numbers: 3071023 3071011 3071039 3061013 3051087 3071034 3031065 3031065 3051054; 3071020; 3061004 3071038 3061033 3061014 3051022; 3061041; 3071070; 3051092; 3071001 3051084; 3071060 3051038 3041051; 3071040 3061025 3071029 3051052 3071027 3071005

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:48 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/food/enforcement.json?search=recall_number:%22F-0134-2014%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.